Background: The Berlin definition of ARDS does not account for nonpulmonary organ failure, which is a major determinant of outcome. We examined whether an increasing severity of hypoxemia across the Berlin definition classifications also corresponded with evidence of multiple organ dysfunction on the day of ARDS onset. We also examined the representation of major etiologies for ARDS across the Berlin definition classifications.

Methods: This single-center, retrospective study examined 15 years of data from a quality assurance program that monitored the use of lung-protective ventilation in ARDS. We analyzed 1,747 subjects without chronic kidney disease or severe chronic liver disease at ARDS onset. The most abnormal laboratory values at ARDS onset were analyzed as cutoff values to assess organ dysfunction. Data were analyzed by using non-parametric analysis of variance (Kruskall-Wallis test) and the Dunn post test. Categorical variables were compared by using the Fisher exact test. Alpha was set at 0.05. Factors independently associated with mortality were assessed by multivariate logistic regression modeling.

Results: Nonpulmonary organ dysfunction was present in at least 1 system at ARDS onset that increased with severity: 80% (mild), 83% (moderate), and 90% (severe). ARDS etiologies varied as severity increased: trauma-associated lung injury steadily decreased, whereas lung injury associated with aspiration and pneumonia steadily increased. Hospital mortality also increased significantly with the Berlin definition classifications: mild (22%), moderate (30%), and severe (47%). Multivariate logistic regression modeling revealed that the Berlin definition of severe ARDS was independently associated with mortality, as were cutoff values for renal and hepatic function as well as acidemia. Normal hematologic function and the absence of standard exclusion criteria used for therapeutic clinical trials in ARDS were protective.

Conclusions: Nonpulmonary organ dysfunction was present at ARDS onset in most subjects and was more pronounced as ARDS severity increased. The Berlin definition classification of ARDS provided an elegant scheme for studying the syndrome because it coincided with increasing multiple organ dysfunction.

Download full-text PDF

Source
http://dx.doi.org/10.4187/respcare.06165DOI Listing

Publication Analysis

Top Keywords

berlin definition
28
organ dysfunction
24
ards onset
20
nonpulmonary organ
16
ards
14
definition classifications
8
multiple organ
8
cutoff values
8
independently associated
8
associated mortality
8

Similar Publications

Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort.

Lancet Diabetes Endocrinol

January 2025

Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Clayton, VIC, Australia; Department of Endocrinology, Monash Health, Clayton, VIC, Australia.

Background: Primary aldosteronism can be treated medically but there is no standardised method to evaluate treatment outcomes. We aimed to develop criteria for assessing the outcomes of targeted medical treatment of primary aldosteronism, analyse outcomes across an international cohort, and identify factors associated with a complete treatment response.

Methods: An international panel of 31 primary aldosteronism experts used the Delphi method to reach consensus on the definition of complete, partial, or absent biochemical and clinical outcomes of medical treatment of primary aldosteronism.

View Article and Find Full Text PDF

Background: Flail chest (FC) injuries are segmental osseous injuries of the thorax that typically result from high-energy blunt trauma and regularly occur in multiple trauma (MT) patients. FC injuries are associated with paradoxical chest wall movements and, thus, have a high risk of respiratory insufficiency or even death. An increasing number of studies recommend an early surgical stabilization of FC injuries, but a definite trigger that would indicate surgery has, thus far, not been identified.

View Article and Find Full Text PDF

Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial.

Lancet Diabetes Endocrinol

January 2025

British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, UK. Electronic address:

Background: Data on the effect of mineralocorticoid receptor antagonist therapy on HbA levels and new-onset diabetes are conflicting. We aimed to examine the effect of oral finerenone, compared with placebo, on incident diabetes in the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients with Heart Failure (FINEARTS-HF) trial.

Methods: In this randomised, double-blind, placebo-controlled trial, 6001 participants with heart failure with New York Heart Association functional class II-IV, left ventricular ejection fraction 40% or higher, evidence of structural heart disease, and elevated N-terminal pro-B-type natriuretic peptide levels were randomly assigned to finerenone or placebo, administered orally.

View Article and Find Full Text PDF

Scapho-metacarpal dual mobility prosthesis for TMC-1 joint salvage: technical insights.

Arch Orthop Trauma Surg

January 2025

BG Klinikum Unfallkrankenhaus Berlin, Department of Hand-, Replantation- and Microsurgery and Chair of Hand-, Replantation- and Microsurgery, Charité Universitätsmedizin Berlin, Berlin, Germany.

Introduction: Rhizarthrosis, or osteoarthritis of the trapeziometacarpal joint, predominantly affects women over 50, with up to 30% experiencing some degree of arthritis in this joint. Traditional surgical approaches, such as trapeziectomy with ligament reconstruction, can result in some patients in persistent pain or limited functionality. TMC ball-in-socket arthroplasty, with a cup placed in the distal scaphoid, offers a promising alternative to traditional arthrodesis or resection-suspension arthroplasty.

View Article and Find Full Text PDF

Purpose: Recent advancements in imaging, particularly 18F-fluorodeoxyglucose positron-emission tomography-computed tomography (FDG-PET/CT), have improved the detection of involved lymph nodes, thus influencing staging accuracy and potentially treatment outcomes. This study is a post hoc analysis of the GAZAI trial data to evaluate the impact of FDG-PET/CT versus computed tomography (CT) alone on radiation target volumes for involved-site radiotherapy (IS-RT) in early-stage follicular lymphoma (FL).

Methods: All patients in the GAZAI trial underwent pretherapeutic FDG-PET/CT examinations, which were subject to central quality control.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!